Abstract
AS NEWER and more potent hypotensive agents become available we may expect to see iatrogenic orthostatic hypotension more frequently. This is particularly true with potent monoamine oxidase inhibitors. This side effect causes serious disability in the recipients. The following brief case reports illustrate this side effect in the course of therapy with a new nonhydrazine monoamine oxidase inhibitor, pargyline hydrochloride. <h3>Report of Cases</h3><h3>Case 1.—</h3> A 57-year-old white normotensive female with involutional depression, insomnia, and crying spells was placed on 25 mg of pargyline hydrochloride daily as part of a clinical evaluation of its effectiveness in depression. After two weeks of therapy the patient noted some slight improvement in her mood, but during the night had to get up to urinate. She walked to the bathroom, where, with no subjective warning, she fell to the floor, striking the side of her head. She does not remember if she lost consciousness.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
